Abcam is a biotechnology business based in the US. Abcam shares (ABCM) are listed on the NASDAQ and all prices are listed in US Dollars. Abcam employs 1,760 staff and has a trailing 12-month revenue of around $379.7 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $20.79 - $24.52 |
| 50-day moving average | $23.39 |
| 200-day moving average | $20.52 |
| Wall St. target price | $1,902.05 |
| PE ratio | 2399 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0 from 2023-12-18
| 1 week (2024-07-15) | nan% |
|---|---|
| 1 month (2024-06-22) | nan% |
| 3 months (2024-04-22) | nan% |
| 6 months (2024-01-22) | nan% |
| 1 year (2023-07-26) | -100.00% |
|---|---|
| 2 years (2022-07-26) | -100.00% |
| 3 years (2021-07-26) | 18.01 |
| 5 years (2019-07-22) | N/A |
Valuing Abcam stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcam's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Abcam's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2399x. In other words, Abcam shares trade at around 2399x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Abcam's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.
Abcam's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $106 million.
The EBITDA is a measure of a Abcam's overall financial performance and is widely used to measure a its profitability.
To put Abcam's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $379.7 million |
|---|---|
| Operating margin TTM | 18.31% |
| Gross profit TTM | $270.5 million |
| Return on assets TTM | 4.36% |
| Return on equity TTM | 0.35% |
| Profit margin | 0.66% |
| Book value | $3.14 |
| Market Capitalization | $5.5 billion |
TTM: trailing 12 months
We're not expecting Abcam to pay a dividend over the next 12 months.
You may also wish to consider:
Abcam's shares were split on a 5:1 basis on 30 November 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Abcam shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Abcam shares which in turn could have impacted Abcam's share price.
Over the last 12 months, Abcam's shares have ranged in value from as little as $20.79 up to $24.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcam's is 0.863. This would suggest that Abcam's shares are less volatile than average (for this exchange).
To put Abcam's beta into context you can compare it against those of similar companies.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.